| 000 | 03231cam a2200385 a 4500 | ||
|---|---|---|---|
| 005 | 20250930130318.0 | ||
| 008 | 100122s2003 sz a b i001 0 eng | ||
| 020 | _a9241546018 | ||
| 039 | 9 |
_a201002051051 _bruzini _y01-22-2010 _zratnab |
|
| 040 | _aUKM | ||
| 060 |
_aW74.1 _b.M235 2003 9 |
||
| 090 | _aW74.1.M235 2003 9 who | ||
| 245 | 0 | 0 |
_aMaking choices in health : _bWHO guide to cost-effectiveness analysis / _cedited by T. Tan-Torres Edejer ... [et al.] |
| 246 | 3 | 0 | _aWHO guide to cost-effectiveness analysis |
| 260 |
_aGeneva : _bWorld Health Organization, _c2003 |
||
| 300 |
_axiii, 312, [8] p. : _bill. ; _c24 cm. |
||
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | _aPart One: METHODS FOR GENERALIZED COST-EFFECTIVENESS -- Ch. 1. What is generalized cost-effectiveness analysis? -- Ch. 2. Undertaking a study using GCEA -- Ch. 3. Estimating costs -- Ch. 4. Estimating health effects -- Ch. 5. Discounting -- Ch. 6. Uncertainty in cost-effectiveness analysis -- Ch. 7. Policy uses of generalized CEA -- Ch. 8. Reporting CEA results -- Ch. 9. Summary of recommendations -- Annex A. WHO-CHOICE activities on generalized cost-effectiveness analysis -- Annex B. Draft list of intervention clusters for evaluation by WHO-CHOICE -- Annex C. An illustration of the types of costs included in a selection of intervention activities at central levels -- Annex D. Interpreting international dollars -- Annex E. DALYs to measure burden of dollars -- Annex F. Measuring intervention benefit at the population level -- Annex G. Epidemiological subregions as applied in WHO generalized CEA -- Part Two: BACKGROUND PAPERS AND APPLICATIONS -- Ch. 1. Development of WHO guidelines on generalized cost-effectiveness analysis -- Ch. 2. PopMod: a longitudinal population model with two interacting disease states -- Ch. 3. Programme costs in the economic evaluation of health interventions -- Ch. 4. Econometric estimation of country-specific hospital costs -- Ch. 5. Stochastic league tables: communicating cost-effectiveness results to decision-makers -- Ch. 6. Uncertainty in cost-effectiveness analysis: probabilistic uncertainty analysis and stochastic league tables -- Ch. 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk -- Ch. 8. Generalized cost-effectiveness analysis: an aid to decision making in health -- Ch. 9. Ethical issues in the use of cost effectiveness analysis for the prioritization of health care resources | |
| 650 | 2 |
_aCost-Benefit Analysis _xmethods |
|
| 650 | 2 |
_aHealth Planning _xmethods |
|
| 650 | 2 |
_aHealth Care Rationing _xeconomics |
|
| 650 | 2 |
_aHealth Priorities _xeconomics |
|
| 650 | 2 | _aPolicy Making | |
| 650 | 2 | _aDecision Support Techniques | |
| 650 | 2 | _aModels, Econometric | |
| 650 | 2 | _aHealth Care Costs | |
| 700 | 1 | _aEdejer, Tessa Tan-Torres | |
| 710 | 2 |
_aWorld Health Organization _948759 |
|
| 907 |
_a.b14646523 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c3 _n0 _kW74.1.M235 2003 9 who |
||
| 914 | _avtls003425153 | ||
| 991 | _aPerpustakaan Dr. Abdul Latiff, KKL | ||
| 998 |
_ad _b2010-09-01 _cm _da _feng _gsz _y0 _z.b14646523 |
||
| 999 |
_c456372 _d456372 |
||